BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10465640)

  • 21. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
    Al-Taie O; Al-Taie E; Fischbach W
    Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic therapy of primary MALT stomach lymphomas--have surgery and radiation been replaced?].
    Böhm SK; Fischbach W
    Z Gastroenterol; 1995 Feb; 33(2):133-4. PubMed ID: 7725760
    [No Abstract]   [Full Text] [Related]  

  • 27. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
    Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
    Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
    Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori.
    Raderer M; Pfeffel F; Pohl G; Mannhalter C; Valencak J; Chott A
    Gut; 2000 Jan; 46(1):133-5. PubMed ID: 10601069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression.
    Morgner A; Bayerdörffer E; Neubauer A; Stolte M
    Gut; 2001 Mar; 48(3):290-2. PubMed ID: 11171813
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies.
    Isaacson PG; Diss TC; Wotherspoon AC; Barbazza R; De Boni M; Doglioni C
    Gastroenterology; 1999 Sep; 117(3):750-1. PubMed ID: 10490369
    [No Abstract]   [Full Text] [Related]  

  • 33. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies.
    Montalban C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Calleja JL; Bellas C
    Ann Oncol; 1997; 8 Suppl 2():37-9. PubMed ID: 9209638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3, 18].
    Kagawa M; Okamura S; Okamoto K; Kitamura S; Kimura T; Niki M; Kaji M; Okahisa T; Yano M; Kagawa S; Kudo E; Sano T; Imoto Y; Wada S; Takayama T
    Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):612-9. PubMed ID: 20379095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
    Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.
    Raderer M; Streubel B; Wöhrer S; Häfner M; Chott A
    Gut; 2006 May; 55(5):616-8. PubMed ID: 16299027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
    Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
    Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
    Kume K; Hirakoba M; Murata I; Yoshikawa I; Otsuki M
    Am J Gastroenterol; 2001 Sep; 96(9):2796-7. PubMed ID: 11569719
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.
    Liu H; Ruskon-Fourmestraux A; Lavergne-Slove A; Ye H; Molina T; Bouhnik Y; Hamoudi RA; Diss TC; Dogan A; Megraud F; Rambaud JC; Du MQ; Isaacson PG
    Lancet; 2001 Jan; 357(9249):39-40. PubMed ID: 11197361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.